Replies to post #218649 on Biotech Values

[DewDiligence]

Right. That's at least a partial explanation for the survey results.

p.s. The upper age bounds (different for men and women) in the labels for Gardasil and Cervarix seem unduly low, even though they are a consequence of the patient pools enrolled in the clinical trials.